These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25216889)

  • 21. Pharmacists' perspectives on HIV testing in community pharmacies.
    Ryder PT; Meyerson BE; Coy KC; von Hippel CD
    J Am Pharm Assoc (2003); 2013; 53(6):595-600. PubMed ID: 24091415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corporate control and professional prerogative: an unresolved tension for pharmacists.
    Clark BE
    Res Social Adm Pharm; 2009 Dec; 5(4):299-301. PubMed ID: 19962672
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacists' experience of conflict in community practice.
    Austin Z; Gregory PA; Martin JC
    Res Social Adm Pharm; 2010 Mar; 6(1):39-48. PubMed ID: 20188327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The General Practitioner-Pharmacist Collaboration (GPPC) study: a randomised controlled trial of clinical medication reviews in community pharmacy.
    Bryant LJ; Coster G; Gamble GD; McCormick RN
    Int J Pharm Pract; 2011 Apr; 19(2):94-105. PubMed ID: 21385240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The provision of current and future Healthy Weight Management (HWM) services from community pharmacies: a survey of community pharmacists' attitudes, practice and future possibilities.
    Newlands RS; Watson MC; Lee AJ
    Int J Pharm Pract; 2011 Apr; 19(2):106-14. PubMed ID: 21385241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
    Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
    Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing pharmacists' role as oral health advisors.
    Cohen LA
    J Am Pharm Assoc (2003); 2013; 53(3):316-21. PubMed ID: 23699681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relevance of political prestudies for implementation studies of cognitive services in community pharmacies.
    Kaae S; Traulsen JM; Søndergaard B; Haugbølle LS
    Res Social Adm Pharm; 2009 Jun; 5(2):189-94. PubMed ID: 19524866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacist participation in health policy development.
    Matzke GR
    Am J Health Syst Pharm; 2016 Feb; 73(3):107. PubMed ID: 26796902
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacy provision of influenza vaccinations in medically underserved communities.
    Murphy PA; Frazee SG; Cantlin JP; Cohen E; Rosan JR; Harshburger DE
    J Am Pharm Assoc (2003); 2012; 52(1):67-70. PubMed ID: 22257618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Existing arrangements for monitoring community pharmacies in England: can they have a role in the revalidation of pharmacists?
    Jacobs S; Schafheutle EI; Jee SD; Elvey R; Hassell K; Noyce PR
    Res Social Adm Pharm; 2013; 9(2):166-77. PubMed ID: 23517658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community pharmacists preventing hospital readmissions.
    Clay PG
    J Am Pharm Assoc (2003); 2014; 54(2):208. PubMed ID: 24632935
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DOTx. MED: Pharmacist-delivered interventions to improve care for patients with diabetes.
    American Pharmacists Association
    J Am Pharm Assoc (2003); 2012; 52(1):25-33. PubMed ID: 22173068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial.
    Williams M; Peterson GM; Tenni PC; Bindoff IK; Curtain C; Hughes J; Bereznicki LR; Jackson SL; Kong DC; Hughes JD
    Ann Pharmacother; 2011 Sep; 45(9):1067-76. PubMed ID: 21878658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacy ownership in Canada: implications for the authority and autonomy of community pharmacy managers.
    Dobson RT; Perepelkin J
    Res Social Adm Pharm; 2011 Dec; 7(4):347-58. PubMed ID: 21272538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring organizational flexibility in community pharmacy: Building the capacity to implement cognitive pharmaceutical services.
    Feletto E; Wilson LK; Roberts AS; Benrimoj SI
    Res Social Adm Pharm; 2011 Mar; 7(1):27-38. PubMed ID: 21397879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
    Wells KM; Thornley T; Boyd MJ; Boardman HF
    Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ontario family physician readiness to collaborate with community pharmacists on drug therapy management.
    Pojskic N; Mackeigan L; Boon H; Ellison P; Breslin C
    Res Social Adm Pharm; 2011 Mar; 7(1):39-50. PubMed ID: 21397880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.